The Patent Finder

Vaxon Biotech

Also on record
Records under this name other than patents Vaxon Biotech holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Vaxon Biotech

PatentTitleStatus Expires Confidence
US 8,663,645Use of native peptides and their optimized derivatives for vaccination
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,900,600Identification, optimization and use of cryptic HLA-A24 epitopes for immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,465,747Identification, optimization and use of cryptic HLA-B7 epitopes for immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,024,868Identification, optimization and use of shared HLA-B*0702 epitopes for immunotherapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,048,737Use of a Vaccine Targeting a Cryptic Tert Epitope, for Treating Cancer in a HLA-A*0201-Positive Patient Having a Non-Immunogenic Tumor Expressing Tert
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,973,128Immunogenic polypeptide composed of tumor antigen-derived optimized cryptic peptides, and uses thereof
Formerly held
In force
Term ended Sep 30, 2026 · From the USPTO record
In forceTerm ended Sep 30, 2026From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited